17554 Holly Well Ave., Tampa, FL 33598
June 30, 2026 Herbalife reported its Q2 results recently. The company sells a significant amount of weight management products in the United States and North America. In July 2026, Herbalife launched Bioniq, their next generation of personalized products, as well as new products within our Life I/O portfolio in North America, which includes a protein-based […]
Herbalife Reports Q2 Results Read More »
June 30, 2026 Management reported Medifast Q2 results, as follows: Second Quarter 2026 • Revenue: $76.4 million, with revenue per active earning coach of $6,529 • Independent active earning coaches of 11,700 • Net loss of $3.1 million or $0.28 loss per diluted share (“EPS”) • Cash, Cash Equivalents, and Investment Securities of $169.8 million
Medifast Reports Q2 2026 Results Read More »
July 17, 2026 Medifast introduces a new program called Trilivy(TM), a science-backed metabolic health system. Trilivy replaces the former Optavia plan, that was focused only on weight loss. According to the press release: The launch also introduces newly formulated meal replacements, including the Trilivy Reset Fueling line enhanced with MetaVantage Technology™, a platform of proprietary
Medifast Launches Trilivy, Replaces Optavia Read More »
April 30, 2025 Herbalife today reported its first quarter 2025 results. The company sells a significant amount of weight management products (meal replacements), and is one the the leading MLM companies selling weight loss products. At $254.4 million, North American sales represented 20.8% of total Herbalife revenues for the quarter. The company had worldwide weight
Herbalife Reports Q1 2025 Results Read More »
August 4, 2022 Medifast reported its Q2 2022 results. Management reported that: “We delivered another solid quarter at Medifast, with revenues up 15%, almost 15% growth in the number of active earning Coaches, and robust Coach productivity. The customized support of OPTAVIA Coaches remains a key differentiator for our business, and these results are a demonstration
Medifast Reports Q2 Results, Stock Price Sinks Read More »
May 2, 2022 “Record quarterly revenues, sharp acceleration in coach metrics and an increase in our annual financial guidance are powerful indications of the underlying strength of our business. We have record numbers of independent active earning OPTAVIA Coaches, helping us drive robust product demand and rapidly increasing digital engagement, and bolstering OPTAVIA to the #1 revenue
Medifast Reports 1st Quarter 2022 Results Read More »
May 6, 2021 Medifast reported results for the first quarter ended March 31, 2021. “This has been an exceptional quarter of growth and productivity, reflecting the outstanding abilities of both our independent OPTAVIA Coaches and our employees,” said Dan Chard, Chairman and Chief Executive Officer of Medifast. “We now have a record 52,500 OPTAVIA Coaches who are achieving new
Medifast Reports Q1 2021 Results – On Track For $1.4 Billion In Sales Read More »
Dec. 29, 2020 “Our business continues to go from strength to strength, with high levels of client demand and engagement among independent OPTAVIA Coaches, accelerated growth and record levels of active earning Coaches,” said Dan Chard, CEO of Medifast. “Our programming efforts this year, along with enhancements to our organization, have given us a foundation for significant
Medifast Reports Q3 Results Read More »
Nov. 7, 2018 — 3rd Quarter 2018 Highlights: Revenue of $139.2 million, an increase of 80.3% year-over-year Active earning Coaches of 22,600, an increase of 59.2% year-over-year Net income of $13.8 million, an increase of 106.1% year-over-year Earnings per diluted share (“EPS”) of $1.14, an increase of 107.3% year-over-year Dan Chard, Medifast’s CEO, said: …”We are
Medifast Reports Q3 Results – Stock Gets Crushed Read More »